Dextran 40 and NovoLog PenFill
Determining the interaction of Dextran 40 and NovoLog PenFill and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dextran, low molecular weight
Brand name: LMD
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextran 40-Novoseven
- Dextran 40-NovoSeven RT
- Dextran 40-NovoSeven RT with MixPro injection
- Dextran 40-Novothyrox
- Dextran 40-Noxafil
- Dextran 40-Noxafil (Posaconazole Delayed-Release Tablets)
- NovoLog PenFill-Dextran 70 6% in 5% Dextrose high molecular weight
- NovoLog PenFill-Dextran 75
- NovoLog PenFill-Dextran high molecular weight
- NovoLog PenFill-Dextranomer and Hyaluronate Derivatives (Deflux)
- NovoLog PenFill-Dextranomer and Hyaluronate Derivatives (Solesta)
- NovoLog PenFill-Dextranomer and sodium hyaluronate